Moleculin Biotech
(NASDAQ:MBRX)
$5.49
-0.05[-0.90%]
Last update: 8:06AM Get Real Time Here
Moleculin Biotech Inc recently split on Friday, March 22, 2024 with a ratio of 1:15
Q4 2023 Earnings were released on Fri Mar 22nd, after the market close
The most recent conference call was at 8:30 AM, 3 days ago Click to view past webcast
50%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
40
0100
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Moleculin Biotech Inc
Sector
Health Care
Industry
Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a bro...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MBRX
ERNA

FAQ

Q

How do I buy Moleculin Biotech (MBRX) stock?

A

You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Moleculin Biotech's (MBRX) competitors?

Q

What is the target price for Moleculin Biotech (MBRX) stock?

A

The latest price target for Moleculin Biotech (NASDAQ: MBRX) was reported by Maxim Group on Tuesday, March 26, 2024. The analyst firm set a price target for 20.00 expecting MBRX to rise to within 12 months (a possible 260.04% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Moleculin Biotech (MBRX)?

A

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $5.555 last updated Today at March 28, 2024 at 9:41 AM EDT.

Q

Does Moleculin Biotech (MBRX) pay a dividend?

A

There are no upcoming dividends for Moleculin Biotech.

Q

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

A

Moleculin Biotech’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Moleculin Biotech (MBRX) going to split?

A

There is no upcoming split for Moleculin Biotech.

Q

What sector and industry does Moleculin Biotech (MBRX) operate in?

A

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch